CASE STUDIES

  • Expanded Access
  • Post-Approval Named Patient
  • Market Access
  • Nursing Solutions
All Case Studies

NEWS

  • 01 Dec 2023
    WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY)
  • 17 Jul 2023
    WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED ACCESS PROTOCOL FOR IMETELSTAT
All News

RESOURCES

Sample Regulatory Assessment for Treatment Access Program

View resource

Sponsor Considerations for Post-Trial Access

View resource
All Resources